Sir Niall Ferguson Joins The Times
The Times announces Sir Niall Ferguson has joined as a contributing writer and will write 12 exclusive pieces per year. He offers his unique insights…
Thought Leader: Niall Ferguson
Rx Drug Policy At The FDA: Looking Back At Gottlieb And Ahead To Sharpless
By Scott Gottlieb (Original source Health Affairs)
“This week is expected to be Dr. Scott Gottlieb’s last as Commissioner of the U.S. Food and Drug Administration (FDA). During his nearly two years in the position, Commissioner Gottlieb has confronted a range of public health challenges, including the opioid epidemic, an increase in teen nicotine abuse, and natural disasters (as this Blog has already considered).”
Click here to see more
Relevant and recent posts
Dr. Sanjay Gupta: Is Ozempic Really A Miracle Drug?
New drugs like Wegovy, Ozempic and Mounjaro are billed as a revolutionary new approach for losing weight. But are these actually miracle drugs? Dr. Sanjay…
Thought Leader: Sanjay Gupta
Peter Zeihan: The Geopolitics of Climate Change
From Peter Zeihan: With a glacier as the backdrop for this video, I figured it only appropriate to discuss resource exploitation, Arctic shipping, and agriculture…
Thought Leader: Peter Zeihan
More with this speaker
Dr. Scott Gottlieb on Trump 2.0
Thought Leader: Scott Gottlieb
Dr. Scott Gottlieb to keynote MM+M Transform in April
Thought Leader: Scott Gottlieb